156 related articles for article (PubMed ID: 36621156)
1. Structural and metabolic correlates of neuropsychological profiles in multiple system atrophy and Parkinson's disease.
Kübler D; Kobylecki C; McDonald KR; Anton-Rodriguez JM; Herholz K; Carter SF; Hinz R; Thompson JC; Al-Fatly B; Gerhard A
Parkinsonism Relat Disord; 2023 Feb; 107():105277. PubMed ID: 36621156
[TBL] [Abstract][Full Text] [Related]
2. [The clinical application value of brain
Gu Q; Chen SF; Chen KL; Huang YY; Ge JJ; Zuo CT; Cui M; Dong Q; Yu JT
Zhonghua Yi Xue Za Zhi; 2023 Nov; 103(41):3294-3300. PubMed ID: 37926574
[No Abstract] [Full Text] [Related]
3. Executive function network's white matter alterations relate to Parkinson's disease motor phenotype.
Yang Q; Nanivadekar S; Taylor PA; Dou Z; Lungu CI; Horovitz SG
Neurosci Lett; 2021 Jan; 741():135486. PubMed ID: 33161103
[TBL] [Abstract][Full Text] [Related]
4. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
[TBL] [Abstract][Full Text] [Related]
5. The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography.
Yoon RG; Kim SJ; Kim HS; Choi CG; Kim JS; Oh J; Chung SJ; Lee CS
Neurosci Lett; 2015 Jan; 584():296-301. PubMed ID: 25450142
[TBL] [Abstract][Full Text] [Related]
6. Clinical features, MRI, and 18F-FDG-PET in differential diagnosis of Parkinson disease from multiple system atrophy.
Zhao P; Zhang B; Gao S; Li X
Brain Behav; 2020 Nov; 10(11):e01827. PubMed ID: 32940411
[TBL] [Abstract][Full Text] [Related]
7. Regional microstructural damage and patterns of eye movement impairment: a DTI and video-oculography study in neurodegenerative parkinsonian syndromes.
Gorges M; Maier MN; Rosskopf J; Vintonyak O; Pinkhardt EH; Ludolph AC; Müller HP; Kassubek J
J Neurol; 2017 Sep; 264(9):1919-1928. PubMed ID: 28762086
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of brain MRI and 18F-FDG PET in the differentiation of Parkinsonian-type multiple system atrophy from Parkinson's disease.
Kwon KY; Choi CG; Kim JS; Lee MC; Chung SJ
Eur J Neurol; 2008 Oct; 15(10):1043-9. PubMed ID: 18717730
[TBL] [Abstract][Full Text] [Related]
9. Characterization and diagnostic potential of diffusion tractography in multiple system atrophy.
Beliveau V; Krismer F; Skalla E; Schocke MM; Gizewski ER; Wenning GK; Poewe W; Seppi K; Scherfler C
Parkinsonism Relat Disord; 2021 Apr; 85():30-36. PubMed ID: 33713904
[TBL] [Abstract][Full Text] [Related]
10. The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy.
Baudrexel S; Seifried C; Penndorf B; Klein JC; Middendorp M; Steinmetz H; Grünwald F; Hilker R
Mov Disord; 2014 Mar; 29(3):380-7. PubMed ID: 24243813
[TBL] [Abstract][Full Text] [Related]
11. Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P.
Kawai Y; Suenaga M; Takeda A; Ito M; Watanabe H; Tanaka F; Kato K; Fukatsu H; Naganawa S; Kato T; Ito K; Sobue G
Neurology; 2008 Apr; 70(16 Pt 2):1390-6. PubMed ID: 18413566
[TBL] [Abstract][Full Text] [Related]
12. Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?
Duncan GW; Firbank MJ; Yarnall AJ; Khoo TK; Brooks DJ; Barker RA; Burn DJ; O'Brien JT
Mov Disord; 2016 Jan; 31(1):103-10. PubMed ID: 26202802
[TBL] [Abstract][Full Text] [Related]
13. Comparison of brain MRI and 18F-FDG PET in the differential diagnosis of multiple system atrophy from Parkinson's disease.
Kwon KY; Choi CG; Kim JS; Lee MC; Chung SJ
Mov Disord; 2007 Dec; 22(16):2352-8. PubMed ID: 17894342
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities of white and grey matter in early multiple system atrophy: comparison of parkinsonian and cerebellar variants.
Dash SK; Stezin A; Takalkar T; George L; Kamble NL; Netravathi M; Yadav R; Kumar KJ; Ingalhalikar M; Saini J; Pal PK
Eur Radiol; 2019 Feb; 29(2):716-724. PubMed ID: 29974222
[TBL] [Abstract][Full Text] [Related]
15. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
[TBL] [Abstract][Full Text] [Related]
16. White matter differences between multiple system atrophy (parkinsonian type) and Parkinson's disease: A diffusion tensor image study.
Ji L; Wang Y; Zhu D; Liu W; Shi J
Neuroscience; 2015 Oct; 305():109-16. PubMed ID: 26215920
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment and structural brain damage in multiple system atrophy-parkinsonian variant.
Caso F; Canu E; Lukic MJ; Petrovic IN; Fontana A; Nikolic I; Kostic VS; Filippi M; Agosta F
J Neurol; 2020 Jan; 267(1):87-94. PubMed ID: 31559533
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cerebral glucose metabolism between multiple system atrophy Parkinsonian type and Parkinson's disease.
Feng T; Wang Y; Ouyang Q; Duan Z; Li W; Lu L; Xiang W
Neurol Res; 2008 May; 30(4):377-82. PubMed ID: 18544255
[TBL] [Abstract][Full Text] [Related]
19. Serotonin Transporter Imaging in Multiple System Atrophy and Parkinson's Disease.
Chou KL; Dayalu P; Koeppe RA; Gilman S; Spears CC; Albin RL; Kotagal V
Mov Disord; 2022 Nov; 37(11):2301-2307. PubMed ID: 36102173
[TBL] [Abstract][Full Text] [Related]
20. Do multiple system atrophy and Parkinson's disease show distinct patterns of volumetric alterations across hippocampal subfields? An exploratory study.
Wang N; Zhang L; Yang H; Luo X; Fan G
Eur Radiol; 2019 Sep; 29(9):4948-4956. PubMed ID: 30796577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
